Regina Grillari's Biography

Regina Grillari, COO/CSO and Co-Founder, Evercyte GmbH

Regina Grillari, co-founder, chief operating and scientific officer of Evercyte has focused on the generation of human relevant and standardizable cell systems for pre-clinical testings and for the production of clinical grade extracellular vesicles in the course of her professional career. Regina has authored and co-authored more than 72 scientific publications and book chapters, and 5 patents. She is also co-founder and scientific advisor of TAmiRNA GmbH (founded 2012) and Phoenestra GmbH (2015).

Human Telomerized Cell Cultures to Establish Relevant and Standardizable Pre-Clinical in vitro Test Systems

Tuesday, 25 June 2024 at 11:00

Add to Calendar ▼2024-06-25 11:00:002024-06-25 12:00:00Europe/LondonHuman Telomerized Cell Cultures to Establish Relevant and Standardizable Pre-Clinical in vitro Test SystemsOrganoids and Spheroids Europe 2024 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

Organ-on-a-chip models mimic physiological conditions to study organ functions in vitro, with their effectiveness depending on cell source choice. Primary cells face challenges like donor variability and limited lifespan, while immortalized cell lines offer indefinite growth and stable characteristics, ideal for long-term studies. Evercyte's immortalized cell lines, resembling primary cells in function and morphology, have been integrated with microfluidic technology to create single and multi-organ chips. This integration replicates critical in vivo elements, providing a robust platform for preclinical research on cellular responses, toxicity, and biomarkers.

Add to Calendar ▼2024-06-24 00:00:002024-06-25 00:00:00Europe/LondonOrganoids and Spheroids Europe 2024Organoids and Spheroids Europe 2024 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors